Table 2.
Cytokine genotype frequencies in patients with or without progression n (%)
| No progression group (n = 137) | Group I (n = 134) | Group II (n = 101) | |
| IL-8-251 | |||
| TT | 59 (43.1) | 39 (29.1) | 25 (24.8) |
| TA | 64 (46.7) | 70 (52.2) | 65 (64.4) |
| AA | 14 (10.2) | 25 (18.7) | 11 (10.9) |
| MIF-173 | |||
| GG | 100 (73.0) | 71 (53.0) | 62 (60.4) |
| GC | 34 (24.8) | 54 (40.3) | 29 (28.7) |
| CC | 3 (2.2) | 9 (6.7) | 10 (10.9) |
IL-8: Interleukin-8; MIF: Migration inhibitory factor. GC: Gastric cancer.